Abstract
We evaluated pulmonary adverse effects and CT appearance of RP after SBRT (48Gy/4fr) and 3D-CRT (60Gy/10fr) for lung tumors. Incidences of Grade≥2RP were 11.6% and 10.5% respectively. No pretreatment factors in SBRT were associated with Grade≥2RP. The minimal lung doses to the RP area in Grade≥2RP patients 1-2 months after radiotherapy (RT) were significantly lower (< 30Gy). We should carefully observe CT appearance of the minimal lung dose area 1-2 months after RT.
| Original language | English |
|---|---|
| Pages (from-to) | 215-221 |
| Number of pages | 7 |
| Journal | Japanese Journal of Clinical Radiology |
| Volume | 58 |
| Issue number | 1 |
| Publication status | Published - 01-2013 |
| Externally published | Yes |
All Science Journal Classification (ASJC) codes
- Radiology Nuclear Medicine and imaging
Fingerprint
Dive into the research topics of 'Pulmonary adverse effects and graphical changes of radiation pneumonitis (RP) after stereotactic body radiation therapy (SBRT) for lung tumors'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver